| # | Drug | Count |
|---|---|---|
| 0 | VEDOLIZUMAB | 21 |
| 1 | PREDNISONE | 11 |
| 2 | ACETAMINOPHEN | 5 |
| 3 | GABAPENTIN | 5 |
| 4 | MESALAMINE | 5 |
| 5 | RITUXIMAB | 5 |
| 6 | VITAMIN C | 5 |
| 7 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 4 |
| 8 | ALEMTUZUMAB | 4 |
| 9 | AZATHIOPRINE | 4 |
| # | Drug class | Count |
|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 21 |
| 1 | Corticosteroid [EPC] | 11 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 8 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| 4 | Vitamin C [EPC] | 6 |
| 5 | Aminosalicylate [EPC] | 5 |
| 6 | Expectorant [EPC] | 5 |
| 7 | Benzodiazepine [EPC] | 4 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 4 |
| 9 | Osmotic Laxative [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vitamin B6 Analog [EPC] | 1 | 0.0028 |
| 1 | Non-Standardized Insect Allergenic Extract [EPC] | 2 | 0.0003 |
| 2 | Standardized Insect Venom Allergenic Extract [EPC] | 2 | 0.0003 |
| 3 | Integrin Receptor Antagonist [EPC] | 21 | 0.0002 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 5 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 6 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 8 | Non-Standardized Plant Allergenic Extract [EPC] | 2 | 0.0001 |
| 9 | Antisense Oligonucleotide [EPC] | 1 | 0.0001 |